An experimental model of cirrhosis in rats, by means carbon tetrachloride (CCl4) and ethanol during two months, was used to assess the effectiveness of S-adenosylmethionine. Histological studies of the liver and examination of different biochemical parameters of hepatic function were also employed. Bilirubin and lactic acid levels decreased significantly in the group treated with S-adenosylmethionine in comparison with the CCl4 + ethanol group. Histologic liver studies showed a significant improvement relative to fatty liver, Mallory bodies, infiltrate polymorphonuclear and perivenular fibrosis. A slight decrease in cirrhosis was observed in the animals treated with S- adenosylmethionine
The potential use of S-adenosyl-L-methionine (SAMe) as therapy for human porphyria cutanea tarda was...
SUMMARY-Rats were submitted to partial hepatectomy, leading to the removal of two thirds of the live...
Experimental models for hepatic lesions are necessary so the effectiveness of new drugs in reversing...
Abstract. S-adenosylmethionine (SAMe) is a key metabolite regulating growth, differentiation and dea...
We studied the effect of cyclosporin A (CyA) on liver plasma membrane (LPM) composition, fluidity, a...
Abstract: We investigated whether S-adenosyl-L-methionine (SAMe), dilinoleoylphosphatidylcholine (DL...
Effects of S-adenosylmethionine (SAME) on hepatic regeneration has been evaluated in hepatectomized ...
In animal models of hepatocellular carcinoma (HCC), deficiency of S-adenosylmethionine (SAMe) increa...
Alterations of methionine cycle in steatohepatitis, cirrhosis, and hepatocellular carcinoma induce M...
S-Adenosyl-L-methionine (SAMe) is a physiologic precursor of thiols and sulfurated compounds, which ...
Background/Aims: Hepatocellular availability of S-adenosylmethionine, the principal biological methy...
Acetaminophen (AAP) overdose causes severe liver injury and is the leading cause of acute liver inju...
<div><p>It has been well established that S-adenosyl-L-methionine (SAMe) is the principal methyl don...
Hepatic lipid metabolism is extremely modified by excessive ethanol consumption, but the cellular me...
SummaryS-adenosyl-l-methionine (SAMe; AdoMet) is an important, metabolically pleiotropic molecule th...
The potential use of S-adenosyl-L-methionine (SAMe) as therapy for human porphyria cutanea tarda was...
SUMMARY-Rats were submitted to partial hepatectomy, leading to the removal of two thirds of the live...
Experimental models for hepatic lesions are necessary so the effectiveness of new drugs in reversing...
Abstract. S-adenosylmethionine (SAMe) is a key metabolite regulating growth, differentiation and dea...
We studied the effect of cyclosporin A (CyA) on liver plasma membrane (LPM) composition, fluidity, a...
Abstract: We investigated whether S-adenosyl-L-methionine (SAMe), dilinoleoylphosphatidylcholine (DL...
Effects of S-adenosylmethionine (SAME) on hepatic regeneration has been evaluated in hepatectomized ...
In animal models of hepatocellular carcinoma (HCC), deficiency of S-adenosylmethionine (SAMe) increa...
Alterations of methionine cycle in steatohepatitis, cirrhosis, and hepatocellular carcinoma induce M...
S-Adenosyl-L-methionine (SAMe) is a physiologic precursor of thiols and sulfurated compounds, which ...
Background/Aims: Hepatocellular availability of S-adenosylmethionine, the principal biological methy...
Acetaminophen (AAP) overdose causes severe liver injury and is the leading cause of acute liver inju...
<div><p>It has been well established that S-adenosyl-L-methionine (SAMe) is the principal methyl don...
Hepatic lipid metabolism is extremely modified by excessive ethanol consumption, but the cellular me...
SummaryS-adenosyl-l-methionine (SAMe; AdoMet) is an important, metabolically pleiotropic molecule th...
The potential use of S-adenosyl-L-methionine (SAMe) as therapy for human porphyria cutanea tarda was...
SUMMARY-Rats were submitted to partial hepatectomy, leading to the removal of two thirds of the live...
Experimental models for hepatic lesions are necessary so the effectiveness of new drugs in reversing...